Mesenchymal stem cells: therapeutic outlook for stroke.

Adult bone marrow-derived mesenchymal stem cells (MSCs) display a spectrum of functional properties. Transplantation of these cells improves clinical outcome in models of cerebral ischemia and spinal cord injury via mechanisms that may include replacement of damaged cells, neuroprotective effects, induction of axonal sprouting, and neovascularization. Therapeutic effects have been reported in animal models of stroke after intravenous delivery of MSCs, including those derived from adult human bone marrow. Initial clinical studies on intravenously delivered MSCs have now been completed in human subjects with stroke. Here, we review the reparative and protective properties of transplanted MSCs in stroke models, describe initial human studies on intravenous MSC delivery in stroke, and provide a perspective on prospects for future progress with MSCs.

[1]  Peter Carmeliet,et al.  Blood vessels and nerves: common signals, pathways and diseases , 2003, Nature Reviews Genetics.

[2]  K. Houkin,et al.  BDNF-Hypersecreting Human Mesenchymal Stem Cells Promote Functional Recovery, Axonal Sprouting, and Protection of Corticospinal Neurons after Spinal Cord Injury , 2009, The Journal of Neuroscience.

[3]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[4]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[5]  M. Chopp,et al.  Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.

[6]  S. Gerson,et al.  Phenotypic and functional comparison of cultures of marrow‐derived mesenchymal stem cells (MSCs) and stromal cells , 1998, Journal of cellular physiology.

[7]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[8]  J. De Keyser.  Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.

[9]  P. Carmeliet,et al.  Molecular analysis of blood vessel formation and disease. , 1997, The American journal of physiology.

[10]  P. Bianco,et al.  Mesenchymal stem cells: revisiting history, concepts, and assays. , 2008, Cell stem cell.

[11]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[12]  K. Houkin,et al.  Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells , 2006, Brain Research.

[13]  D. Bates,et al.  Regulation of microvascular permeability by vascular endothelial growth factors * , 2002, Journal of anatomy.

[14]  K. Houkin,et al.  I.v. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2005, Neuroscience.

[15]  S. Harper,et al.  Regulation of vascular permeability by vascular endothelial growth factors. , 2002, Vascular pharmacology.

[16]  A. Álvarez-Buylla,et al.  For the Long Run Maintaining Germinal Niches in the Adult Brain , 2004, Neuron.

[17]  Arnold I Caplan,et al.  The MSC: an injury drugstore. , 2011, Cell stem cell.

[18]  Yi Li,et al.  Ischemic rat brain extracts induce human marrow stromal cell growth factor production , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[19]  K. Houkin,et al.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat , 2006, Experimental Neurology.

[20]  J. Kocsis,et al.  Development of a Middle Cerebral Artery Occlusion Model in the Nonhuman Primate and a Safety Study of I.V. Infusion of Human Mesenchymal Stem Cells , 2011, PloS one.

[21]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[22]  K. Houkin,et al.  BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  K. Houkin,et al.  Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. , 2003, Experimental hematology.

[24]  D. Prockop,et al.  Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Kocsis,et al.  Focal experimental autoimmune encephalomyelitis in the lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor , 2010, Glia.

[26]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[27]  K. Houkin,et al.  Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia , 2009, Experimental Neurology.

[28]  A. Caplan.  Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. , 2005, Tissue engineering.

[29]  M. Chopp,et al.  Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat , 2003, Journal of neuroscience research.

[30]  I. Weissman,et al.  Hematopoietic cells maintain hematopoietic fates upon entering the brain , 2005, The Journal of experimental medicine.

[31]  Takuya Matsunaga,et al.  Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. , 2011, Brain : a journal of neurology.

[32]  M. Luskin,et al.  Neuronal Progenitor Cells Derived from the Anterior Subventricular Zone of the Neonatal Rat Forebrain Continue to Proliferatein Vitroand Express a Neuronal Phenotype , 1997, Molecular and Cellular Neuroscience.

[33]  M. Chopp,et al.  One-Year Follow-Up After Bone Marrow Stromal Cell Treatment in Middle-Aged Female Rats With Stroke , 2007, Stroke.

[34]  K. Houkin,et al.  Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. , 2006, Brain : a journal of neurology.

[35]  K. Houkin,et al.  Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat , 2006, Journal of neuroscience research.

[36]  B R Rosen,et al.  Activation of distinct motor cortex regions during ipsilateral and contralateral finger movements. , 1999, Journal of neurophysiology.

[37]  M Chopp,et al.  Magnetization transfer MRI: Application to treatment of middle cerebral artery occlusion in rat , 2001, Journal of magnetic resonance imaging : JMRI.

[38]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[39]  Thomas N. Sato,et al.  Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.

[40]  J. Rafols,et al.  Pericyte migration from the vascular wall in response to traumatic brain injury. , 2000, Microvascular research.

[41]  N. Ikeda,et al.  VASCULAR ENDOTHELIAL GROWTH FACTOR GENE‐TRANSFERRED BONE MARROW STROMAL CELLS ENGINEERED WITH A HERPES SIMPLEX VIRUS TYPE 1 VECTOR CAN IMPROVE NEUROLOGICAL DEFICITS AND REDUCE INFARCTION VOLUME IN RAT BRAIN ISCHEMIA , 2007, Neurosurgery.

[42]  O. Bang,et al.  A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke , 2010, Stem cells.

[43]  M. Chopp,et al.  Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery , 2002, Neurology.

[44]  K. Houkin,et al.  Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  M. Chopp,et al.  Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. , 2002, Trends in cardiovascular medicine.

[46]  D. McDonald,et al.  Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. , 2006, American journal of physiology. Heart and circulatory physiology.

[47]  K. Houkin,et al.  A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats , 2004, Brain Research.

[48]  Xuejin Chen,et al.  An improved protocol that induces human embryonic stem cells to differentiate into neural cells in vitro , 2008, Cell biology international.

[49]  I. Black,et al.  Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.

[50]  H. Dvorak,et al.  Stable Expression of Angiopoietin-1 and Other Markers by Cultured Pericytes: Phenotypic Similarities to a Subpopulation of Cells in Maturing Vessels During Later Stages of Angiogenesis In Vivo , 2002, Laboratory Investigation.

[51]  M. Chopp,et al.  Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.

[52]  J. LaManna,et al.  The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems , 2004, Neurological research.

[53]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.